Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2023 1
2024 2
2025 5
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
SGLT2 inhibition and adipose tissue metabolism: current outlook and perspectives.
Morciano C, Gugliandolo S, Capece U, Di Giuseppe G, Mezza T, Ciccarelli G, Soldovieri L, Brunetti M, Avolio A, Splendore A, Pontecorvi A, Giaccari A, Cinti F. Morciano C, et al. Cardiovasc Diabetol. 2024 Dec 19;23(1):449. doi: 10.1186/s12933-024-02539-x. Cardiovasc Diabetol. 2024. PMID: 39702365 Free PMC article. Review.
The effects of SGLT2i on cardiac metabolism in patients with HFpEF: Fact or fiction?
Cinti F, Laborante R, Cappannoli L, Morciano C, Gugliandolo S, Pontecorvi A, Burzotta F, Donniacuo M, Cappetta D, Patti G, Giaccari A, D'Amario D. Cinti F, et al. Among authors: morciano c. Cardiovasc Diabetol. 2025 May 14;24(1):208. doi: 10.1186/s12933-025-02767-9. Cardiovasc Diabetol. 2025. PMID: 40369599 Free PMC article. Review.
Erythrocyte Membrane Fluidity and Omega-3 Fatty Acid Intake: Current Outlook and Perspectives for a Novel, Nutritionally Modifiable Cardiovascular Risk Factor.
Capece U, Gugliandolo S, Morciano C, Avolio A, Splendore A, Di Giuseppe G, Ciccarelli G, Soldovieri L, Brunetti M, Mezza T, Pontecorvi A, Giaccari A, Cinti F. Capece U, et al. Among authors: morciano c. Nutrients. 2024 Dec 14;16(24):4318. doi: 10.3390/nu16244318. Nutrients. 2024. PMID: 39770939 Free PMC article. Review.
Coronary flow reserve increase after 4-year dapagliflozin treatment in patients with type 2 diabetes: the DAPAHEART follow-up study.
Cinti F, Morciano C, Guarneri A, Cappannoli L, Sorice G, Gugliandolo S, Capece U, Splendore A, Avolio A, Mezza T, Iozzo P, Pontecorvi A, Calcagni ML, Burzotta F, D'Amario D, Crea F, Leccisotti L, Giaccari A. Cinti F, et al. Among authors: morciano c. Cardiovasc Diabetol. 2025 Aug 31;24(1):351. doi: 10.1186/s12933-025-02912-4. Cardiovasc Diabetol. 2025. PMID: 40887630 Free PMC article. Clinical Trial.
Dapagliflozin treatment is associated with a reduction of epicardial adipose tissue thickness and epicardial glucose uptake in human type 2 diabetes.
Cinti F, Leccisotti L, Sorice GP, Capece U, D'Amario D, Lorusso M, Gugliandolo S, Morciano C, Guarneri A, Guzzardi MA, Mezza T, Capotosti A, Indovina L, Ferraro PM, Iozzo P, Crea F, Giordano A, Giaccari A. Cinti F, et al. Among authors: morciano c. Cardiovasc Diabetol. 2023 Dec 19;22(1):349. doi: 10.1186/s12933-023-02091-0. Cardiovasc Diabetol. 2023. PMID: 38115004 Free PMC article. Clinical Trial.
In humans increase in intrapancreatic adipose tissue predicts beta-cell dedifferentiation score before diabetes onset: A pilot study.
Cinti F, Mezza T, Severi I, Moffa S, Giuseppe GD, Capece U, Ciccarelli G, Soldovieri L, Brunetti M, Morciano C, Gugliandolo S, Senzacqua M, Avolio A, Quero G, Tondolo V, Nista EC, Moroni R, Cinti S, Alfieri S, Gasbarrini A, Pontecorvi A, Giaccari A. Cinti F, et al. Among authors: morciano c. Diabetes Res Clin Pract. 2025 Mar;221:112029. doi: 10.1016/j.diabres.2025.112029. Epub 2025 Feb 10. Diabetes Res Clin Pract. 2025. PMID: 39938572 Free article.
Corrigendum to "In humans increase in intrapancreatic adipose tissue predicts beta-cell dedifferentiation score before diabetes onset: A pilot study" [Diabetes Res. Clin. Pr. 221 (2025) MS N. 112029].
Cinti F, Mezza T, Severi I, Moffa S, Giuseppe GD, Capece U, Ciccarelli G, Soldovieri L, Brunetti M, Morciano C, Gugliandolo S, Senzacqua M, Avolio A, Quero G, Tondolo V, Nista EC, Moroni R, Cinti S, Alfieri S, Gasbarrini A, Pontecorvi A, Giaccari A. Cinti F, et al. Among authors: morciano c. Diabetes Res Clin Pract. 2025 Jul;225:112097. doi: 10.1016/j.diabres.2025.112097. Epub 2025 Mar 17. Diabetes Res Clin Pract. 2025. PMID: 40102093 Free article. No abstract available.